Allogeneic Stem Cell Transplantation for Patients with Acute Myeloid Leukemia (AML) in Second Complete Remission (CR2) Transplanted from Unrelated Donors with Post-transplant Cyclophosphamide (PTCy). A Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

By
Jamie Kang
-
0
152
Investigators retrospectively evaluated transplant outcomes of adult AML patients transplanted between 2010–2019 from 9–10/10 human leukocyte antigen-matched unrelated donors in CR2.
[Bone Marrow Transplantation]
Abstract